The mRNA vaccines market, valued at USD 12 million in 2025, is projected to reach USD 9 million in 2026 and USD 7,047 million by 2035 (this represents the market opportunityonly for mRNA vaccines developed for non-COVID applications). In terms of target indication, the respiratory syncytial virus (RSV) infection is likely to capture the majority of the current revenue share. In terms of geographical regions, North America accounts for the largest market share, primarily due to increased research...

The stem cell therapy market, valued at USD 204 million in 2025, is projected to reach USD 321 million in 2026 and USD 1,290 million by 2035, representing a CAGR of 16.7% during the forecast period 2026 to 2035. Based on end users, hospitals dominate the overall market as they possess the specialized infrastructure and expertise required to administer advanced stem cell therapies. Across key geographical regions, North America captures the largest market share owing to substantial research fundi...

The global AI in drug discovery market, valued at USD 6.0 billion in 2025, is projected to reach USD 8.6 billion in 2026 and USD 25.0 billion by 2035, representing a CAGR of 12.6% during the forecast period 2026 to 2035. In terms of application, lead optimization holds the largest share (around 50%) of the current market. With respect to the type of AI technology, machine learning dominates the current market, accounting for 40% revenue share.

The global prefilled syringes market, valued at USD 3,818 million in 2025, is projected to reach USD 4,122 million in 2026 and USD 6,750 million by 2035, representing a CAGR of 5.6% during the forecast period 2026 to 2035. In terms of therapeutic area, the market for hematological disorders is likely to capture the highest share (more than 65%) of the global prefilled syringes industry in 2026 due to the high volume of anticoagulants and blood stimulants standardized for delivery via prefilled f...

The global oral solid dosage contract manufacturing market, valued at USD 23.4 billion in 2025, is projected to reach USD 24.6 billion in 2026 and USD 39.4 billion by 2035, with a CAGR of 5.39% during the forecast period 2026 to 2035. In terms of type of finished dosage form, tablets account for the highest share (more than 70%) of the market in 2026. Based on the type of packaging, bottles are likely to occupy the largest share of the market in 2035.

The global climate tech market is expected to rise from USD 46.5 billion in 2026 and is projected to reach USD 691.4 billion by 2040, growing at a CAGR of 21.3% over the forecast period 2026 to 2040, driven by electrification and industrial decarbonization. Current growth comes from electrification, grid modernization, corporate procurement, and policy-backed infrastructure financing. Germany’s government planned EUR 13.3 billion in 2027 energy-cost relief during July 2026, including grid-fee...

The peptide therapeutics market, valued at USD 90.2 billion in 2025, is projected to reach USD 108.2 billion in 2026 and USD 233.6 billion by 2035, representing a CAGR of 8.9% during the forecast period 2026 to 2035. These therapies mimic naturally occurring biological processes and have gained widespread adoption across metabolic disorders, cancer, hormonal deficiencies, and autoimmune diseases. In recent years, the commercial success of peptide-based drugs, particularly GLP-1 receptor agonists...

The heart failure drugs market, valued at USD 7.84 billion in 2025, is projected to reach USD 9.19 billion in 2026 and USD 12.31 billion by 2035. Heart failure is a chronic condition in which the heart is unable to pump sufficient blood into different organs. Further, in order to mitigate the growing incidence, pharmaceutical companies have developed heart failure drugs that can target wide range of conditions, such as managing fluid build-up, improving cardiac contractility, controlling blood p...

The global voluntary carbon credit market, valued at USD 1.6 billion in 2025, is projected to grow to USD 2.6 billion in 2026 and USD 47.5 billion by 2035, representing a CAGR of 38% during the forecast period 2026 to 2035. Based on the application area, the industrial sector captures the largest (around 35%) share of the market, and this trend is unlikely to change. In May 2026, the Singapore government and the World Bank Group jointly launched the Singapore Carbon Markets Program at the Innova...

The global rapid transfer port market size, valued at USD 502 million in 2025, is projected to reach USD 522 million in 2026 and USD 962 million by 2035, with a CAGR of 7.0% during the forecast period 2026 to 2035. With the rising complexity of aseptic processing and the critical need for absolute sterility assurance in high-value biologics, the industry has observed increased stringency in the regulatory framework of the USFDA and the EU for market approval and compliance.In terms of type of be...

The global therapeutic vaccines market, valued at USD 6.7 billion in 2025, is projected to reach USD 11.0 billion in 2026 and USD 86.8 billion by 2035, representing a CAGR of 25.8% during the forecast period 2026 to 2035. In terms of type of vaccine, the peptide vaccines segment holds the highest share (close to 45%) of the current market. Over the last few years, this segment of the industry has witnessed substantial partnership activity and investment from various private and public sector inv...

The global squamous non-small cell lung cancer market, valued at USD 9.3 billion in 2025, is projected to reach USD 10.0 billion in 2026 and USD 18.3 billion by 2035, representing a CAGR of 7.9% during the forecast period 2026 to 2035. In terms of therapeutic type, the immunotherapies segment holds the highest share (more than 35%) of the current market. In the absence of suitable targeted therapies, immunotherapy with or without chemotherapy has become the cornerstone of squamous NSCLC treatmen...

The chromatography market, valued at USD 12.05 billion in 2025, is projected to reach USD 12.65 billion in 2026 and USD 22.35 billion by 2035, with a 6.53% CAGR during the forecast period 2026 to 2035. In September 2025, Testa Analytical entered into an agreement with Mazet & Co to expand the access of their flow measurement technologies across French-speaking regions of Europe and North Africa. The collaboration aims to enhance customer support in these markets and underscore the commitment of...

The global drug reconstitution systems market, valued at USD 5.4 billion in 2025, is projected to reach USD 5.9 billion in 2026 and USD 10.8 billion by 2035, representing a CAGR of 7.0% during the forecast period 2026 to 2035. In terms of type of reconstitution system, cartridges hold the highest share (close to 50%) of the current market. Based on fabrication material, the glass segment holds the largest share of the current market.

The global chromatography consumables market, valued at USD 5.6 billion in 2025, is projected to reach USD 6.0 billion in 2026 and USD 9.7 billion by 2035, representing a CAGR of 5.6% during the forecast period 2026 to 2035. In terms of product, columns hold the highest (around 45%) share of the current market. With respect to chromatography technique, liquid chromatography dominates the current market. In April 2026, Merck completed the acquisition of JSR Life Sciences’ chromatography busines...

The global agricultural biologicals market, valued at USD 16.62 billion in 2025, is projected to reach USD 18.27 billion in 2026 and USD 43.53 billion by 2035, representing a CAGR of 10.1% during the forecast period 2026 to 2035. In May 2026, IPL Biologicals opened its third manufacturing plant in Vadodara, Gujarat, raising its annual production capacity to 7,000 KL/year to strengthen its supply chain capabilities and meet the growing demand for these biologicals in India and export markets. In...

The GLP-1 receptor agonist market size, valued at USD 78 billion in 2025, is projected to reach USD 101.4 billion in 2026 and USD 180 billion by 2035, representing a CAGR of 6.6% during the forecast period 2026 to 2035. In recent years, there has been a notable shift in consumer lifestyles driven by the growing influence of social media, celebrity endorsements and direct-to-consumer advertising. This has led to a surge in the demand for weight loss and type 2 diabetes treatment solutions, which...

The next generation drug conjugates market, valued at USD 8.0 billion in 2025, is projected to reach USD 11.2 billion in 2026 and USD 26.2 billion by 2035, representing a CAGR of 9.9% during the forecast period 2026 to 2035. In terms of type of drug conjugate, ligand mediated RNAi conjugates hold the highest share (around 55%) of the current market. With respect to type of targeting ligand, next generation drug conjugates with amino sugar dominate (more than 60%) the current market.

The global anti-aging drugs for dogs market, valued at USD 0.09 billion in 2026, is projected to reach USD 6.16 billion by 2040, with a 36% CAGR during the forecast period 2026 to 2040. Over the years, the pet dog population has increased at a substantial rate. According to the American Veterinary Medical Association, the dog population has steadily increased from 52.9 million in 1996 to 89.7 million in 2024. Also, the number of pet-owning households has increased from 31.3 million in 1996 to 59...

The global anti-obesity drugs market, valued at USD 28.2 billion in 2025, is projected to reach USD 45.1 billion in 2026 and USD 106.5 billion by 2035, representing a CAGR of 10.0% during the forecast period 2026 to 2035. In terms of route of administration, parenteral route captures the highest share of the current market.Based on the distribution channel, retail and online pharmacies are likely to capture the highest share of the current market. In terms of key geographical regions, North Amer...